Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Yoshida, Haruhiko; Shiratori, Yasushi; Moriyama, Mitsuhiko; Arakawa, Yasuyuki; Ide, Tatsuya; Sata, Michio; Inoue, Osami; Yano, Michitami; Tanaka, Motohiko; Fujiyama, Shigetoshi; Nishiguchi, Shuhei; Kuroki, Tetsuo; Imazeki, Fumio; Yokosuka, Osamu; Kinoyama, Shingo; Yamada, Gotaro; Omata, Masao; the IHIT Study Group, for

doi:10.7326/0003-4819-131-3-199908030-00003

Public

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Published in Annals of Internal Medicine • Aug 3, 1999

Authors:

Haruhiko Yoshida

Yasushi Shiratori

Mitsuhiko Moriyama

Abstract

BACKGROUND: Previous studies on the effect of interferon therapy on the incidence of hepatocellular carcinoma have not sufficiently assessed degree of liver fibrosis, a major risk factor for hepatocellular carcinoma. OBJECTIVE: To evaluate the effect of interferon therapy on incidence of hepatocellu...

Subject

Medicine

Hepatocellular carcinoma

Gastroenterology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!